Lusutrombopag
CAS 1110766-97-6Small Molecule
Overview
Lusutrombopag is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2107831).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Lusutrombopag expires 29 Sept 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (E)-3-[2,6-dichloro-4-[[4-[3-[(1S)-1-hexoxyethyl]-2-methoxyphenyl]-1,3-thiazol-2-yl]carbamoyl]phenyl]-2-methylprop-2-enoic acid
- Canonical SMILES
- CCCCCCO[C@@H](C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)/C=C(\C)/C(=O)O)Cl
- InChIKey
- NOZIJMHMKORZBA-KJCUYJGMSA-N
Verified Supplier Partner
Do you supply Lusutrombopag? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.